Association of HLA-DR gene polymorphism and rheumatoid arthritis associated genes (PADI4 and IRF5 polymorphisms) with juvenile idiopathic arthritis.
Not Applicable
- Conditions
- juvenile idiopathic arthritis
- Registration Number
- JPRN-UMIN000002864
- Lead Sponsor
- Department of Pediatrics, Yokohama City University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
The patient judged as improper case for enrollment in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of juvenile idiopathic arthritis
- Secondary Outcome Measures
Name Time Method Subgroup analysis based on (1) subtype of JIA (systemic onset or oligoarticular/polyarticular onset), (2) response to therapy, (3) the level of anti-citrullinated peptide antibodies, rheumatoid factor, antinuclear antibody, or matrix metalloproteiase-3, (4) family history of rheumatic disease and autoimmune disease,(5) complications such as macrophage activation syndrome and uveitis